Advanced utilization of yeast RNA extracted from Candida utilus fermented in pulp waste liquor パルプ廃液の処理工程で副生するCandida utilus酵母RNAの高度利用

この論文をさがす

著者

    • 小島, 鋭士 コジマ, エイジ

書誌事項

タイトル

Advanced utilization of yeast RNA extracted from Candida utilus fermented in pulp waste liquor

タイトル別名

パルプ廃液の処理工程で副生するCandida utilus酵母RNAの高度利用

著者名

小島, 鋭士

著者別名

コジマ, エイジ

学位授与大学

京都大学

取得学位

博士 (農学)

学位授与番号

乙第10143号

学位授与年月日

1999-03-23

注記・抄録

博士論文

目次

  1. 論文目録 / (0001.jp2)
  2. CONTENTS / p1 (0006.jp2)
  3. General Introduction / p1 (0008.jp2)
  4. Chapter1. Synthesis of novel 2',3'-dideoxynucleosides and antiviral evaluation for them / p4 (0010.jp2)
  5. 1.1 Chapter's Introduction / p4 (0010.jp2)
  6. 1.2 Synthesis and structure-activity relationships of 2',3'-dideoxypurine nucleosides as potential antiretroviral agents / p5 (0010.jp2)
  7. 1.3 Escherichia coli mediated biosynthesis and in vitro anti-HIV activity of lipophilic 6-halo-2',3'-dideoxypurine nucleosides / p11 (0013.jp2)
  8. 1.4 Lipophilic halogenated congeners of 2',3'-dideoxypurine nucleosides active against human immunodeficiency virus in vitro / p37 (0026.jp2)
  9. 1.5 Chapter's Summary / p55 (0035.jp2)
  10. Chapter2. Development of novel clinical evaluation method for anti-retroviral agents using RT-PCR and pre-clinical study of SK034 / p58 (0037.jp2)
  11. 2.1 Chapter's Introduction / p58 (0037.jp2)
  12. 2.2 Quantification of viral load in patients with HIV-1 infection receiving combination chemothetapy of AZT with ddl / p59 (0037.jp2)
  13. 2.3 Monitoring the activity of antiviral therapy for HIV infection using a polymerase chain reaction method coupled with reverse transcription / p67 (0041.jp2)
  14. 2.4 Human immunodeficiency virus type I(HIV-1)viremia changes and development of drug-related mutations in patients with symptomatic HIV-1 infection receiving alternating or simultaneous zidovudine and didanosine therapy / p80 (0048.jp2)
  15. 2.5 Preclinical study of SK034 using Rhesus Monkeys with SIV and the evaluation of efficacy by RT-PCR / p101 (0058.jp2)
  16. 2.6 Chapter's Summary / p113 (0064.jp2)
  17. Chapter3. Trials about synthesis of nucleosides having novel chemical structure and biological evaluations / p115 (0065.jp2)
  18. 3.1 Chapter's Introduction / p115 (0065.jp2)
  19. 3.2 Synthesis and antiviral evaluation of 2,6-diamino-9-(N-p-toluenesulfonyl-pyrrolidinyl-2-methyl)-purine / p116 (0066.jp2)
  20. 3.3 Novel purine derivatives and their anti-HIV activities / p122 (0069.jp2)
  21. 3.4 Structure-activity relationships among purines having arylsulfonyl moiety / p127 (0071.jp2)
  22. 3.5 The result of anti-tumor screening as to 2,6-diamino-9-(N-p-toluenesulfonyl-pyrrolidinyl-2-methyl)-purine / p132 (0074.jp2)
  23. 3.6 Chapter's Summary / p139 (0077.jp2)
  24. General Summary / p140 (0078.jp2)
  25. References and Notes / p144 (0080.jp2)
  26. Acknowledgements / p159 (0087.jp2)
  27. Appendix I.~V. / p161 (0088.jp2)
0アクセス

各種コード

  • NII論文ID(NAID)
    500000170587
  • NII著者ID(NRID)
    • 8000000170861
  • DOI(NDL)
  • NDL書誌ID
    • 000000334901
  • データ提供元
    • NDL-OPAC
    • NDLデジタルコレクション
ページトップへ